$SMG
SCOTTS MIRACLE-GRO CO

2021 Q1 Form 10-Q Financial Statement

#000154638021000009 Filed on February 10, 2021

View on sec.gov

Income Statement

Concept 2021 Q1 2019 Q4
Revenue $748.6M $365.8M
YoY Change -45.86% 22.71%
Cost Of Revenue $548.8M $311.3M
YoY Change -33.82% 19.23%
Gross Profit $190.8M $54.20M
YoY Change -65.32% 57.1%
Gross Profit Margin 25.49% 14.82%
Selling, General & Admin $156.7M $119.8M
YoY Change -19.89% 3.01%
% of Gross Profit 82.13% 221.03%
Research & Development $10.30M $9.200M
YoY Change 6.19% 0.0%
% of Gross Profit 5.4% 16.97%
Depreciation & Amortization $15.70M $14.80M
YoY Change -33.19% 5.71%
% of Gross Profit 8.23% 27.31%
Operating Expenses $156.7M $119.8M
YoY Change -19.89% 3.01%
Operating Profit $34.00M -$62.60M
YoY Change -90.39% -26.27%
Interest Expense $16.10M $20.00M
YoY Change -29.07% -20.63%
% of Operating Profit 47.35%
Other Income/Expense, Net $15.20M $2.600M
YoY Change 442.86% -10.34%
Pretax Income $33.10M -$95.10M
YoY Change -90.08% -10.2%
Income Tax $7.900M -$23.80M
% Of Pretax Income 23.87%
Net Earnings $24.40M -$71.40M
YoY Change -90.33% -10.3%
Net Earnings / Revenue 3.26% -19.52%
Basic Earnings Per Share $0.44 -$1.28
Diluted Earnings Per Share $0.43 -$1.28
COMMON SHARES
Basic Shares Outstanding 55.70M shares 55.80M shares
Diluted Shares Outstanding 57.10M shares 55.80M shares

Balance Sheet

Concept 2021 Q1 2019 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $21.50M $27.40M
YoY Change -30.19% 21.24%
Cash & Equivalents $21.50M $27.40M
Short-Term Investments
Other Short-Term Assets $92.00M $203.3M
YoY Change -3.97% 98.34%
Inventory $1.068B $866.1M
Prepaid Expenses
Receivables $346.6M $192.7M
Other Receivables $0.00 $0.00
Total Short-Term Assets $1.680B $1.333B
YoY Change -17.77% 23.56%
LONG-TERM ASSETS
Property, Plant & Equipment $560.9M $545.4M
YoY Change 4.76% 4.92%
Goodwill $548.9M $540.9M
YoY Change 1.97% 0.22%
Intangibles $685.4M $701.7M
YoY Change -0.95% -17.14%
Long-Term Investments $202.9M $0.00
YoY Change -100.0%
Other Assets $323.1M $335.2M
YoY Change -1.37% 65.2%
Total Long-Term Assets $2.321B $2.123B
YoY Change 10.89% -1.09%
TOTAL ASSETS
Total Short-Term Assets $1.680B $1.333B
Total Long-Term Assets $2.321B $2.123B
Total Assets $4.001B $3.456B
YoY Change -3.26% 7.16%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $498.9M $309.4M
YoY Change 53.65% 30.55%
Accrued Expenses $52.90M $45.00M
YoY Change 18.61%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $188.0M $93.80M
YoY Change -11.4% -1.37%
Total Short-Term Liabilities $1.055B $609.7M
YoY Change 7.47% 2.54%
LONG-TERM LIABILITIES
Long-Term Debt $1.980B $1.970B
YoY Change -6.34% -9.89%
Other Long-Term Liabilities $287.4M $247.1M
YoY Change 16.78% 45.95%
Total Long-Term Liabilities $2.267B $2.217B
YoY Change -3.93% -5.88%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.055B $609.7M
Total Long-Term Liabilities $2.267B $2.217B
Total Liabilities $3.322B $2.827B
YoY Change -0.58% -4.89%
SHAREHOLDERS EQUITY
Retained Earnings $1.224B $1.170B
YoY Change -11.85% 40.03%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost) $958.8M $903.1M
YoY Change 1.79% -3.69%
Treasury Stock Shares 12.60M shares 12.40M shares
Shareholders Equity $672.6M $624.6M
YoY Change
Total Liabilities & Shareholders Equity $4.001B $3.456B
YoY Change -3.26% 7.16%

Cashflow Statement

Concept 2021 Q1 2019 Q4
OPERATING ACTIVITIES
Net Income $24.40M -$71.40M
YoY Change -90.33% -10.3%
Depreciation, Depletion And Amortization $15.70M $14.80M
YoY Change -33.19% 5.71%
Cash From Operating Activities -$420.7M -$318.2M
YoY Change 45.62% 36.33%
INVESTING ACTIVITIES
Capital Expenditures $34.60M $21.90M
YoY Change -561.33% 72.44%
Acquisitions $10.00M $0.00
YoY Change -100.0%
Other Investing Activities $2.900M $1.300M
YoY Change -97.48% -159.09%
Cash From Investing Activities -$148.2M -$25.70M
YoY Change -237.48% 50.29%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $38.40M $0.00
YoY Change -100.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $573.5M $352.3M
YoY Change 210.0% 46.85%
NET CHANGE
Cash From Operating Activities -$420.7M -$318.2M
Cash From Investing Activities -$148.2M -$25.70M
Cash From Financing Activities $573.5M $352.3M
Net Change In Cash $4.900M $8.600M
YoY Change 25.64% -176.11%
FREE CASH FLOW
Cash From Operating Activities -$420.7M -$318.2M
Capital Expenditures $34.60M $21.90M
Free Cash Flow -$455.3M -$340.1M
YoY Change 61.8% 38.2%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q1 dei Entity Central Index Key
EntityCentralIndexKey
0000825542
CY2021Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--09-30
CY2021Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
6300000 USD
CY2019Q4 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
2700000 USD
CY2021Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
CY2021Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2021Q1 dei Amendment Flag
AmendmentFlag
false
CY2021Q1 dei Document Type
DocumentType
10-Q
CY2021Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2021Q1 dei Document Period End Date
DocumentPeriodEndDate
2021-01-02
CY2021Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2021Q1 dei Entity File Number
EntityFileNumber
001-11593
CY2021Q1 dei Entity Registrant Name
EntityRegistrantName
Scotts Miracle-Gro Co
CY2021Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
OH
CY2021Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
31-1414921
CY2021Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
14111 Scottslawn Road,
CY2021Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Marysville,
CY2021Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
OH
CY2021Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
43041
CY2021Q1 dei City Area Code
CityAreaCode
937
CY2021Q1 dei Local Phone Number
LocalPhoneNumber
644-0011
CY2021Q1 dei Security12b Title
Security12bTitle
Common Shares, $0.01 stated value
CY2021Q1 dei Trading Symbol
TradingSymbol
SMG
CY2021Q1 dei Security Exchange Name
SecurityExchangeName
NYSE
CY2021Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2021Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2021Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2021Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2021Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2021Q1 dei Entity Shell Company
EntityShellCompany
false
CY2021Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
55703094 shares
CY2021Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
748600000 USD
CY2019Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
365800000 USD
CY2021Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
548800000 USD
CY2019Q4 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
311300000 USD
CY2021Q1 smg Cost Of Sales Impairment Restructuring And Other Charges
CostOfSalesImpairmentRestructuringAndOtherCharges
9000000.0 USD
CY2019Q4 smg Cost Of Sales Impairment Restructuring And Other Charges
CostOfSalesImpairmentRestructuringAndOtherCharges
300000 USD
CY2021Q1 us-gaap Gross Profit
GrossProfit
190800000 USD
CY2019Q4 us-gaap Gross Profit
GrossProfit
54200000 USD
CY2021Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
156700000 USD
CY2019Q4 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
119800000 USD
CY2021Q1 us-gaap Restructuring Settlement And Impairment Provisions
RestructuringSettlementAndImpairmentProvisions
700000 USD
CY2019Q4 us-gaap Restructuring Settlement And Impairment Provisions
RestructuringSettlementAndImpairmentProvisions
-2500000 USD
CY2021Q1 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
600000 USD
CY2019Q4 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
500000 USD
CY2021Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
34000000.0 USD
CY2019Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-62600000 USD
CY2021Q1 smg Costs Relatedto Refinancing Noncash
CostsRelatedtoRefinancingNoncash
0 USD
CY2019Q4 smg Costs Relatedto Refinancing Noncash
CostsRelatedtoRefinancingNoncash
15100000 USD
CY2021Q1 us-gaap Interest Expense
InterestExpense
16100000 USD
CY2019Q4 us-gaap Interest Expense
InterestExpense
20000000.0 USD
CY2021Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
15200000 USD
CY2019Q4 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
2600000 USD
CY2021Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
33100000 USD
CY2019Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-95100000 USD
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
7900000 USD
CY2019Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-23800000 USD
CY2021Q1 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
25200000 USD
CY2019Q4 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-71300000 USD
CY2021Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
0 USD
CY2019Q4 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
0 USD
CY2021Q1 us-gaap Profit Loss
ProfitLoss
25200000 USD
CY2019Q4 us-gaap Profit Loss
ProfitLoss
-71300000 USD
CY2021Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
800000 USD
CY2019Q4 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
100000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
24400000 USD
CY2019Q4 us-gaap Net Income Loss
NetIncomeLoss
-71400000 USD
CY2021Q1 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.44
CY2019Q4 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-1.28
CY2021Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0
CY2019Q4 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.44
CY2019Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.28
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
55700000 shares
CY2019Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
55800000 shares
CY2021Q1 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.43
CY2019Q4 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-1.28
CY2021Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
0
CY2019Q4 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
0
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.43
CY2019Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.28
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
57100000 shares
CY2019Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
55800000 shares
CY2021Q1 us-gaap Profit Loss
ProfitLoss
25200000 USD
CY2019Q4 us-gaap Profit Loss
ProfitLoss
-71300000 USD
CY2021Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
12400000 USD
CY2019Q4 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
4600000 USD
CY2021Q1 us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
2500000 USD
CY2019Q4 us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
-1400000 USD
CY2021Q1 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci On Derivatives Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax
-1900000 USD
CY2019Q4 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci On Derivatives Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax
-800000 USD
CY2021Q1 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci Pension And Other Postretirement Benefit Plans Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax
-1200000 USD
CY2019Q4 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci Pension And Other Postretirement Benefit Plans Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax
-1100000 USD
CY2021Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
15600000 USD
CY2019Q4 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
2900000 USD
CY2021Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
40800000 USD
CY2019Q4 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-68400000 USD
CY2021Q1 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
800000 USD
CY2019Q4 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
100000 USD
CY2021Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
40000000.0 USD
CY2019Q4 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-68500000 USD
CY2021Q1 us-gaap Profit Loss
ProfitLoss
25200000 USD
CY2019Q4 us-gaap Profit Loss
ProfitLoss
-71300000 USD
CY2021Q1 smg Costs Relatedto Refinancing Noncash
CostsRelatedtoRefinancingNoncash
0 USD
CY2019Q4 smg Costs Relatedto Refinancing Noncash
CostsRelatedtoRefinancingNoncash
15100000 USD
CY2021Q1 us-gaap Share Based Compensation
ShareBasedCompensation
8200000 USD
CY2019Q4 us-gaap Share Based Compensation
ShareBasedCompensation
7000000.0 USD
CY2021Q1 us-gaap Depreciation
Depreciation
15700000 USD
CY2019Q4 us-gaap Depreciation
Depreciation
14800000 USD
CY2021Q1 us-gaap Adjustment For Amortization
AdjustmentForAmortization
7400000 USD
CY2019Q4 us-gaap Adjustment For Amortization
AdjustmentForAmortization
7600000 USD
CY2021Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-1800000 USD
CY2019Q4 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-2100000 USD
CY2021Q1 us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
-12500000 USD
CY2019Q4 us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
0 USD
CY2021Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1100000 USD
CY2019Q4 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-72900000 USD
CY2021Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
442800000 USD
CY2019Q4 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
324700000 USD
CY2021Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
10200000 USD
CY2019Q4 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
26800000 USD
CY2021Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
126800000 USD
CY2019Q4 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
114200000 USD
CY2021Q1 us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
-125700000 USD
CY2019Q4 us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
-115700000 USD
CY2021Q1 us-gaap Increase Decrease In Restructuring Reserve
IncreaseDecreaseInRestructuringReserve
-700000 USD
CY2019Q4 us-gaap Increase Decrease In Restructuring Reserve
IncreaseDecreaseInRestructuringReserve
-2300000 USD
CY2021Q1 us-gaap Increase Decrease In Other Noncurrent Assets And Liabilities Net
IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet
11300000 USD
CY2019Q4 us-gaap Increase Decrease In Other Noncurrent Assets And Liabilities Net
IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet
6500000 USD
CY2021Q1 smg Increase Decrease In Other Net
IncreaseDecreaseInOtherNet
100000 USD
CY2019Q4 smg Increase Decrease In Other Net
IncreaseDecreaseInOtherNet
400000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-420700000 USD
CY2019Q4 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-318200000 USD
CY2021Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
34600000 USD
CY2019Q4 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
21900000 USD
CY2021Q1 us-gaap Payments For Proceeds From Loans Receivable
PaymentsForProceedsFromLoansReceivable
0 USD
CY2019Q4 us-gaap Payments For Proceeds From Loans Receivable
PaymentsForProceedsFromLoansReceivable
2500000 USD
CY2021Q1 us-gaap Payments To Acquire Interest In Subsidiaries And Affiliates
PaymentsToAcquireInterestInSubsidiariesAndAffiliates
100700000 USD
CY2019Q4 us-gaap Payments To Acquire Interest In Subsidiaries And Affiliates
PaymentsToAcquireInterestInSubsidiariesAndAffiliates
0 USD
CY2021Q1 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
10000000.0 USD
CY2019Q4 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0 USD
CY2021Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
2900000 USD
CY2019Q4 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
1300000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-148200000 USD
CY2019Q4 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-25700000 USD
CY2021Q1 us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
712900000 USD
CY2019Q4 us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
465700000 USD
CY2021Q1 us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
67500000 USD
CY2019Q4 us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
112800000 USD
CY2021Q1 us-gaap Proceeds From Issuance Of Senior Long Term Debt
ProceedsFromIssuanceOfSeniorLongTermDebt
0 USD
CY2019Q4 us-gaap Proceeds From Issuance Of Senior Long Term Debt
ProceedsFromIssuanceOfSeniorLongTermDebt
450000000.0 USD
CY2021Q1 us-gaap Repayments Of Senior Debt
RepaymentsOfSeniorDebt
0 USD
CY2019Q4 us-gaap Repayments Of Senior Debt
RepaymentsOfSeniorDebt
400000000.0 USD
CY2021Q1 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
0 USD
CY2019Q4 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
18600000 USD
CY2021Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
34600000 USD
CY2019Q4 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
32400000 USD
CY2021Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
38400000 USD
CY2019Q4 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
0 USD
CY2021Q1 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
0 USD
CY2019Q4 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
500000 USD
CY2021Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1100000 USD
CY2019Q4 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
900000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
573500000 USD
CY2019Q4 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
352300000 USD
CY2021Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
300000 USD
CY2019Q4 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
200000 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
4900000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
8600000 USD
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
16600000 USD
CY2019Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
18800000 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
21500000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
27400000 USD
CY2021Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
21500000 USD
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
27400000 USD
CY2020Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
16600000 USD
CY2021Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
6800000 USD
CY2019Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
4200000 USD
CY2020Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
7500000 USD
CY2021Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
346600000 USD
CY2019Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
192700000 USD
CY2020Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
474800000 USD
CY2021Q1 us-gaap Pledged Assets Separately Reported Finance Receivables Pledged As Collateral At Fair Value
PledgedAssetsSeparatelyReportedFinanceReceivablesPledgedAsCollateralAtFairValue
151100000 USD
CY2019Q4 us-gaap Pledged Assets Separately Reported Finance Receivables Pledged As Collateral At Fair Value
PledgedAssetsSeparatelyReportedFinanceReceivablesPledgedAsCollateralAtFairValue
43300000 USD
CY2020Q3 us-gaap Pledged Assets Separately Reported Finance Receivables Pledged As Collateral At Fair Value
PledgedAssetsSeparatelyReportedFinanceReceivablesPledgedAsCollateralAtFairValue
22300000 USD
CY2021Q1 us-gaap Inventory Net
InventoryNet
1068300000 USD
CY2019Q4 us-gaap Inventory Net
InventoryNet
866100000 USD
CY2020Q3 us-gaap Inventory Net
InventoryNet
621900000 USD
CY2020Q3 us-gaap Inventory Net
InventoryNet
621900000 USD
CY2021Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
92000000.0 USD
CY2019Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
203300000 USD
CY2020Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
81000000.0 USD
CY2021Q1 us-gaap Assets Current
AssetsCurrent
1679500000 USD
CY2019Q4 us-gaap Assets Current
AssetsCurrent
1332800000 USD
CY2020Q3 us-gaap Assets Current
AssetsCurrent
1216600000 USD
CY2021Q1 us-gaap Equity Method Investments
EquityMethodInvestments
202900000 USD
CY2019Q4 us-gaap Equity Method Investments
EquityMethodInvestments
0 USD
CY2020Q3 us-gaap Equity Method Investments
EquityMethodInvestments
0 USD
CY2021Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
698800000 USD
CY2019Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
642200000 USD
CY2020Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
682100000 USD
CY2021Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
560900000 USD
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
545400000 USD
CY2020Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
560000000.0 USD
CY2021Q1 us-gaap Goodwill
Goodwill
548900000 USD
CY2019Q4 us-gaap Goodwill
Goodwill
540900000 USD
CY2020Q3 us-gaap Goodwill
Goodwill
544100000 USD
CY2021Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
685400000 USD
CY2019Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
701700000 USD
CY2020Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
679200000 USD
CY2021Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
323100000 USD
CY2019Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
335200000 USD
CY2020Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
380600000 USD
CY2021Q1 us-gaap Assets
Assets
4000700000 USD
CY2019Q4 us-gaap Assets
Assets
3456000000.0 USD
CY2020Q3 us-gaap Assets
Assets
3380500000 USD
CY2021Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
188000000.0 USD
CY2019Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
93800000 USD
CY2020Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
66400000 USD
CY2021Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
498900000 USD
CY2019Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
309400000 USD
CY2020Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
391000000.0 USD
CY2021Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
367600000 USD
CY2019Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
206500000 USD
CY2020Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
493000000.0 USD
CY2021Q1 us-gaap Liabilities Current
LiabilitiesCurrent
1054500000 USD
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
609700000 USD
CY2020Q3 us-gaap Liabilities Current
LiabilitiesCurrent
950400000 USD
CY2021Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1979800000 USD
CY2019Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1969900000 USD
CY2020Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1455100000 USD
CY2021Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
287400000 USD
CY2019Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
247100000 USD
CY2020Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
272100000 USD
CY2021Q1 us-gaap Liabilities
Liabilities
3321700000 USD
CY2019Q4 us-gaap Liabilities
Liabilities
2826700000 USD
CY2020Q3 us-gaap Liabilities
Liabilities
2677600000 USD
CY2021Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2019Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2020Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
55600000 shares
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
55800000 shares
CY2020Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
55800000 shares
CY2021Q1 us-gaap Common Stocks Including Additional Paid In Capital
CommonStocksIncludingAdditionalPaidInCapital
490500000 USD
CY2019Q4 us-gaap Common Stocks Including Additional Paid In Capital
CommonStocksIncludingAdditionalPaidInCapital
448900000 USD
CY2020Q3 us-gaap Common Stocks Including Additional Paid In Capital
CommonStocksIncludingAdditionalPaidInCapital
482500000 USD
CY2021Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
1224400000 USD
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
1169800000 USD
CY2020Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
1235600000 USD
CY2021Q1 us-gaap Treasury Stock Shares
TreasuryStockShares
12600000 shares
CY2019Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
12400000 shares
CY2020Q3 us-gaap Treasury Stock Shares
TreasuryStockShares
12400000 shares
CY2021Q1 us-gaap Treasury Stock Value
TreasuryStockValue
958800000 USD
CY2019Q4 us-gaap Treasury Stock Value
TreasuryStockValue
903100000 USD
CY2020Q3 us-gaap Treasury Stock Value
TreasuryStockValue
921800000 USD
CY2021Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-83500000 USD
CY2019Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-91000000.0 USD
CY2020Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-99100000 USD
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
672600000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
624600000 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
697200000 USD
CY2021Q1 us-gaap Minority Interest
MinorityInterest
6400000 USD
CY2019Q4 us-gaap Minority Interest
MinorityInterest
4700000 USD
CY2020Q3 us-gaap Minority Interest
MinorityInterest
5700000 USD
CY2021Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
679000000.0 USD
CY2019Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
629300000 USD
CY2020Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
702900000 USD
CY2021Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
4000700000 USD
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3456000000.0 USD
CY2020Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3380500000 USD
CY2021Q1 smg Percentage Of Annual Net Sales
PercentageOfAnnualNetSales
0.75
CY2021Q1 us-gaap Interest Paid Net
InterestPaidNet
23000000.0 USD
CY2019Q4 us-gaap Interest Paid Net
InterestPaidNet
28100000 USD
CY2021Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
200000 USD
CY2019Q4 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
-2100000 USD
CY2020Q4 us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
100700000 USD
CY2020Q4 us-gaap Notes Receivable Net
NotesReceivableNet
66400000 USD
CY2021Q1 smg Gain Loss On Change In Fair Value Of Financing Receivable
GainLossOnChangeInFairValueOfFinancingReceivable
12500000 USD
CY2021Q1 us-gaap Loans Receivable Fair Value Disclosure
LoansReceivableFairValueDisclosure
78900000 USD
CY2020Q4 us-gaap Equity Method Investments Fair Value Disclosure
EquityMethodInvestmentsFairValueDisclosure
23300000 USD
CY2021Q1 smg Total Impairment Restructuring And Other Charges Recoveries
TotalImpairmentRestructuringAndOtherChargesRecoveries
9700000 USD
CY2019Q4 smg Total Impairment Restructuring And Other Charges Recoveries
TotalImpairmentRestructuringAndOtherChargesRecoveries
-2200000 USD
CY2020Q3 us-gaap Restructuring Reserve
RestructuringReserve
3900000 USD
CY2021Q1 smg Restructuring And Other Related Charges Continuing Operations
RestructuringAndOtherRelatedChargesContinuingOperations
9700000 USD
CY2021Q1 smg Payments For Restructuring And Other
PaymentsForRestructuringAndOther
10400000 USD
CY2021Q1 us-gaap Restructuring Reserve
RestructuringReserve
3200000 USD
CY2021Q1 us-gaap Restructuring Reserve Noncurrent
RestructuringReserveNoncurrent
1100000 USD
CY2019Q4 us-gaap Inventory Net
InventoryNet
866100000 USD
CY2020Q3 us-gaap Inventory Net
InventoryNet
621900000 USD
CY2021Q1 us-gaap Inventory Finished Goods
InventoryFinishedGoods
768400000 USD
CY2019Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
609200000 USD
CY2020Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
390300000 USD
CY2021Q1 us-gaap Inventory Work In Process
InventoryWorkInProcess
84000000.0 USD
CY2019Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
79100000 USD
CY2020Q3 us-gaap Inventory Work In Process
InventoryWorkInProcess
164800000 USD
CY2021Q1 us-gaap Inventory Raw Materials
InventoryRawMaterials
215900000 USD
CY2019Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
177800000 USD
CY2020Q3 us-gaap Inventory Raw Materials
InventoryRawMaterials
66800000 USD
CY2021Q1 us-gaap Inventory Net
InventoryNet
1068300000 USD
CY2021Q1 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
23900000 USD
CY2019Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
11400000 USD
CY2020Q3 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
31300000 USD
CY2021Q1 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
2177200000 USD
CY2019Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
2074500000 USD
CY2020Q3 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
1531200000 USD
CY2021Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
188000000.0 USD
CY2021Q1 smg Lessee Operating Lease Lease Not Yet Commenced Liability
LesseeOperatingLeaseLeaseNotYetCommencedLiability
45300000 USD
CY2019Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
93800000 USD
CY2020Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
66400000 USD
CY2021Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1979800000 USD
CY2019Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1969900000 USD
CY2020Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1455100000 USD
CY2021Q1 us-gaap Debt Weighted Average Interest Rate
DebtWeightedAverageInterestRate
0.038
CY2019Q4 us-gaap Debt Weighted Average Interest Rate
DebtWeightedAverageInterestRate
0.045
CY2020Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
702900000 USD
CY2021Q1 us-gaap Profit Loss
ProfitLoss
25200000 USD
CY2021Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
15600000 USD
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
8200000 USD
CY2021Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.62
CY2021Q1 us-gaap Dividends
Dividends
35700000 USD
CY2021Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
38400000 USD
CY2021Q1 us-gaap Stock Issued During Period Value Treasury Stock Reissued
StockIssuedDuringPeriodValueTreasuryStockReissued
1200000 USD
CY2021Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
679000000.0 USD
CY2019Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
723200000 USD
CY2019Q4 us-gaap Profit Loss
ProfitLoss
-71300000 USD
CY2019Q4 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
2900000 USD
CY2019Q4 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
7000000.0 USD
CY2019Q4 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.58
CY2019Q4 us-gaap Dividends
Dividends
33500000 USD
CY2019Q4 us-gaap Stock Issued During Period Value Treasury Stock Reissued
StockIssuedDuringPeriodValueTreasuryStockReissued
900000 USD
CY2019Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
629300000 USD
CY2021Q1 us-gaap Oci Before Reclassifications Before Tax Attributable To Parent
OciBeforeReclassificationsBeforeTaxAttributableToParent
15800000 USD
CY2021Q1 us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Before Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
-1000000.0 USD
CY2021Q1 us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
1200000 USD
CY2021Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
15600000 USD
CY2019Q4 us-gaap Oci Before Reclassifications Before Tax Attributable To Parent
OciBeforeReclassificationsBeforeTaxAttributableToParent
2700000 USD
CY2019Q4 us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Before Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
300000 USD
CY2019Q4 us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
-500000 USD
CY2019Q4 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
2900000 USD
CY2019Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.58
CY2020Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.62
CY2019Q3 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
500000000.0 USD
us-gaap Stock Repurchase Program Period In Force1
StockRepurchaseProgramPeriodInForce1
P5Y
CY2016Q3 smg Additional Shares Authorized For Repurchase Value
AdditionalSharesAuthorizedForRepurchaseValue
500000000.0 USD
CY2020Q1 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
1000000000.0 USD
CY2019Q4 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
0 shares
us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
8700000 shares
us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
762800000 USD
CY2020Q1 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
750000000.0 USD
CY2020 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
0 shares
CY2021Q1 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
200000 shares
CY2021Q1 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
38000000.0 USD
CY2021Q1 us-gaap Residual Value Of Leased Asset
ResidualValueOfLeasedAsset
4100000 USD
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
2282 shares
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
5042 shares
CY2021Q1 us-gaap Stock Granted During Period Value Sharebased Compensation
StockGrantedDuringPeriodValueSharebasedCompensation
300000 USD
CY2019Q4 us-gaap Stock Granted During Period Value Sharebased Compensation
StockGrantedDuringPeriodValueSharebasedCompensation
500000 USD
CY2021Q1 us-gaap Share Based Compensation
ShareBasedCompensation
8200000 USD
CY2019Q4 us-gaap Share Based Compensation
ShareBasedCompensation
7000000.0 USD
CY2021Q1 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
2000000.0 USD
CY2019Q4 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
1700000 USD
CY2021Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
169600000 USD
CY2019Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
129500000 USD
CY2020Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
156000000.0 USD
CY2021Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.239
CY2019Q4 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.250
CY2021Q1 us-gaap Loss Contingency Disclosures
LossContingencyDisclosures
CONTINGENCIES<div style="margin-top:8pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management regularly evaluates the Company’s contingencies, including various lawsuits and claims which arise in the normal course of business, product and general liabilities, workers’ compensation, property losses and other liabilities for which the Company is self-insured or retains a high exposure limit. Self-insurance accruals are established based on actuarial loss estimates for specific individual claims plus actuarially estimated amounts for incurred but not reported claims and adverse development factors applied to existing claims. Legal costs incurred in connection with the resolution of claims, lawsuits and other contingencies generally are expensed as incurred. In the opinion of management, the assessment of contingencies is reasonable and related accruals, in the aggregate, are adequate; however, there can be no assurance that final resolution of these matters will not have a material effect on the Company’s financial condition, results of operations or cash flows. </span></div><div style="margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Regulatory Matters</span></div><div style="margin-top:8pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At January 2, 2021, $3.8 was accrued in the “Other liabilities” line in the Condensed Consolidated Balance Sheets for environmental actions, the majority of which are for site remediation. The Company believes that the amounts accrued are adequate to cover such known environmental exposures based on current facts and estimates of likely outcomes. Although it is reasonably possible that the costs to resolve such known environmental exposures will exceed the amounts accrued, any variation from accrued amounts is not expected to be material.</span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Other</span></div><div style="margin-top:8pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has been named as a defendant in a number of cases alleging injuries that the lawsuits claim resulted from exposure to asbestos-containing products, apparently based on the Company’s historic use of vermiculite in certain of its products. In many of these cases, the complaints are not specific about the plaintiffs’ contacts with the Company or its products. The cases vary, but complaints in these cases generally seek unspecified monetary damages (actual, compensatory, consequential and punitive) from multiple defendants. The Company believes that the claims against it are without merit and is vigorously defending against them. No accruals have been recorded in the Company’s consolidated financial statements as the likelihood of a loss is not probable at this time; and the Company does not believe a reasonably possible loss would be material to, nor the ultimate resolution of these cases will have a material adverse effect on, the Company’s financial condition, results of operations or cash flows. There can be no assurance that future developments related to pending claims or claims filed in the future, whether as a result of adverse outcomes or as a result of significant defense costs, will not have a material effect on the Company’s financial condition, results of operations or cash flows. </span></div><div style="margin-top:8pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is involved in other lawsuits and claims which arise in the normal course of business. These claims individually and in the aggregate are not expected to result in a material effect on the Company’s financial condition, results of operations or cash flows.</span></div>
CY2021Q1 us-gaap Accrual For Environmental Loss Contingencies Gross
AccrualForEnvironmentalLossContingenciesGross
3800000 USD
CY2021Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
52900000 USD
CY2019Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
45000000.0 USD
CY2020Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
47500000 USD
CY2021Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
122900000 USD
CY2019Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
88900000 USD
CY2020Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
113300000 USD
CY2021Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
175800000 USD
CY2019Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
133900000 USD
CY2020Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
160800000 USD
CY2021Q1 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
33300000 USD
CY2019Q4 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
36300000 USD
CY2020Q3 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
34700000 USD
CY2021Q1 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
5200000 USD
CY2019Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
4500000 USD
CY2020Q3 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
5200000 USD
CY2021Q1 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
29600000 USD
CY2019Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
32400000 USD
CY2020Q3 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
30900000 USD
CY2021Q1 us-gaap Finance Lease Liability
FinanceLeaseLiability
34800000 USD
CY2019Q4 us-gaap Finance Lease Liability
FinanceLeaseLiability
36900000 USD
CY2020Q3 us-gaap Finance Lease Liability
FinanceLeaseLiability
36100000 USD
CY2021Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
15400000 USD
CY2019Q4 us-gaap Operating Lease Cost
OperatingLeaseCost
13100000 USD
CY2021Q1 us-gaap Variable Lease Cost
VariableLeaseCost
3100000 USD
CY2019Q4 us-gaap Variable Lease Cost
VariableLeaseCost
2300000 USD
CY2021Q1 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
1500000 USD
CY2019Q4 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
900000 USD
CY2021Q1 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
400000 USD
CY2019Q4 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
300000 USD
CY2021Q1 smg Finance Lease Cost
FinanceLeaseCost
1900000 USD
CY2019Q4 smg Finance Lease Cost
FinanceLeaseCost
1200000 USD
CY2021Q1 smg Operating Lease Right Of Use Asset Amortization
OperatingLeaseRightOfUseAssetAmortization
13300000 USD
CY2019Q4 smg Operating Lease Right Of Use Asset Amortization
OperatingLeaseRightOfUseAssetAmortization
11100000 USD
CY2021Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
13900000 USD
CY2019Q4 us-gaap Operating Lease Payments
OperatingLeasePayments
13400000 USD
CY2021Q1 us-gaap Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
400000 USD
CY2019Q4 us-gaap Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
300000 USD
CY2021Q1 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
1300000 USD
CY2019Q4 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
400000 USD
CY2021Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
25600000 USD
CY2019Q4 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
11000000.0 USD
CY2021Q1 us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
0 USD
CY2019Q4 us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
11900000 USD
CY2021Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P4Y7M6D
CY2021Q1 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P8Y3M18D
CY2021Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.037
CY2021Q1 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.043
CY2021Q1 smg Lessee Operating Lease Liability To Be Paid After Year Four
LesseeOperatingLeaseLiabilityToBePaidAfterYearFour
21300000 USD
CY2021Q1 smg Finance Lease Liability To Be Paid After Year Four
FinanceLeaseLiabilityToBePaidAfterYearFour
14800000 USD
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
45000000.0 USD
CY2021Q1 us-gaap Finance Lease Liability Payments Remainder Of Fiscal Year
FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear
4900000 USD
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
48600000 USD
CY2021Q1 us-gaap Finance Lease Liability Payments Due Next Twelve Months
FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
6500000 USD
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
33200000 USD
CY2021Q1 us-gaap Finance Lease Liability Payments Due Year Two
FinanceLeaseLiabilityPaymentsDueYearTwo
6600000 USD
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
24800000 USD
CY2021Q1 us-gaap Finance Lease Liability Payments Due Year Three
FinanceLeaseLiabilityPaymentsDueYearThree
6600000 USD
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
18700000 USD
CY2021Q1 us-gaap Finance Lease Liability Payments Due Year Four
FinanceLeaseLiabilityPaymentsDueYearFour
2400000 USD
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
191600000 USD
CY2021Q1 us-gaap Finance Lease Liability Payments Due
FinanceLeaseLiabilityPaymentsDue
41800000 USD
CY2021Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
15800000 USD
CY2021Q1 us-gaap Finance Lease Liability Undiscounted Excess Amount
FinanceLeaseLiabilityUndiscountedExcessAmount
7000000.0 USD
CY2021Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
175800000 USD
CY2021Q1 us-gaap Finance Lease Liability
FinanceLeaseLiability
34800000 USD
CY2021Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
3 segment
CY2021Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
748600000 USD
CY2019Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
365800000 USD
CY2021Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
748600000 USD
CY2019Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
365800000 USD
CY2021Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
748600000 USD
CY2019Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
365800000 USD

Files In Submission

Name View Source Status
0001546380-21-000009-index-headers.html Edgar Link pending
0001546380-21-000009-index.html Edgar Link pending
0001546380-21-000009.txt Edgar Link pending
0001546380-21-000009-xbrl.zip Edgar Link pending
exhibit21smg20210102.htm Edgar Link pending
exhibit22smg20210102.htm Edgar Link pending
exhibit311smg20210102.htm Edgar Link pending
exhibit312smg20210102.htm Edgar Link pending
exhibit32smg20210102.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
smg-20210102.htm Edgar Link pending
smg-20210102.xsd Edgar Link pending
smg-20210102_cal.xml Edgar Link unprocessable
smg-20210102_def.xml Edgar Link unprocessable
smg-20210102_htm.xml Edgar Link completed
smg-20210102_lab.xml Edgar Link unprocessable
smg-20210102_pre.xml Edgar Link unprocessable